|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0400 USD | 0.00% |
|
+31.58% | +53.85% |
| 05-18 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 0.1211 | 0.3469 | 0.3469 |
| Spread/Res. | -66.97% | -88.47% | -88.47% |
| Spread/Supp. | +2,566.67% | +2,566.67% | +2,566.67% |
| Support | 0.0015 | 0.0015 | 0.0015 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ADAPY Stock
- Charts Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
